ACTUATE THERAPEUTICS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ACTUATE THERAPEUTICS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($5.41M) | Nov 13, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($5.95M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($5.95M) | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($6.32M) | May 15, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($6.32M) | Nov 13, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($6.32M) | Aug 14, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($5.97M) | Nov 13, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($6.57M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($6.57M) | Aug 14, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($8.30M) | Nov 13, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($8.30M) | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($8.30M) | May 15, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($6.34M) | Nov 13, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($5.52M) | Sep 24, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($5.52M) | Nov 13, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($5.27M) | Sep 24, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($5.27M) | Nov 13, 2024 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($5.47M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($5.97M) | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($6.37M) | May 15, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($5.39M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($5.44M) | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($7.77M) | May 15, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($6.48M) | Nov 13, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($5.58M) | Sep 24, 2024 |